VEGF

8 registered clinical trials studyying VEGF — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant NCT06984822	Vastra Gotaland Region	N/A
Active Not Recruiting	The Effects of Age on Wound Healing on Free Gingival Graft Surgery in the Treatment of Attached Keratinized Gi NCT06749119	Marmara University	N/A
Unknown	Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma NCT05675033	Fujian Cancer Hospital	Phase 2
Unknown	Effects of Anti-VEGF Targeted Drugs on Patients' Blood Pressure and Endothelial Function NCT04962438	Peking University Third Hospital	—
Unknown	Study of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients NCT03114826	Centre Hospitalier Universitaire, Amiens	—
Completed	A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-t NCT01379534	Novartis Pharmaceuticals	Phase 2
Completed	Topical Bevacizumab for Preventing Recurrent Pterygium NCT01311960	Chulalongkorn University	Phase 3
Unknown	Pregnancy Rates in IVF After Ovulation Triggering With Recombinant or Urinary Human Chorionic Gonadotrophin (H NCT00954265	Universitair Ziekenhuis Brussel	Phase 3